Page last updated: 2024-12-09

4-thiopyridine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

4-thiopyridine: RN given refers to 4-thiopyridine cpd [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID2723889
CHEMBL ID1688955
SCHEMBL ID73739
MeSH IDM0126358

Synonyms (41)

Synonym
4-mercaptopyridine
pyridine-4-thiol
4-thiopyridine
brn 0105392
4-pyridinethione
4(1h)-pyridinethione
einecs 224-926-1
nsc 76036
brn 0105869
nsc76036
pyridine, 4-mercapto-
nsc-76036
4-pyridinethiol
4556-23-4
4-mercaptopyridine, 95%
AKOS000187925
4-pyridyl mercaptan
M0630
1h-pyridine-4-thione
CHEMBL1688955
19829-29-9
A826843
5-21-07-00167 (beilstein handbook reference)
BP-10932
FT-0646236
AM20051197
SCHEMBL73739
FG-0489
FHTDDANQIMVWKZ-UHFFFAOYSA-N
4mercaptopyridine
4-mercapto pyridine
4-mercapto-pyridine
A1-01079
AC-24180
pyridine-4(1h)-thione
mfcd00006422
EN300-100322
CS-W013664
1-methylindoline-5-sulfonyl chloride?
DTXSID70878773
F10307

Research Excerpts

Bioavailability

ExcerptReferenceRelevance
"Chemical speciation of heavy metals has become extremely important in environmental and analytical research because of the strong dependence that toxicity, environmental mobility, persistence and bioavailability of these pollutants have on their specific chemical forms."( Chemical speciation of heavy metals by surface-enhanced Raman scattering spectroscopy: identification and quantification of inorganic- and methyl-mercury in water.
Alvarez-Puebla, RA; Correa-Duarte, MA; GarcĂ­a de Abajo, FJ; Guerrini, L; Lee, YH; Ling, XY; Rodriguez-Loureiro, I, 2014
)
0.4
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (4)

Assay IDTitleYearJournalArticle
AID584546Inhibition of inosine/L-alanine-induced Bacillus anthracis Sterne 34F2 spore germination pretreated for 15 mins before inosine/L-alanine challenge2010Antimicrobial agents and chemotherapy, Dec, Volume: 54, Issue:12
Testing nucleoside analogues as inhibitors of Bacillus anthracis spore germination in vitro and in macrophage cell culture.
AID584549Activation of Bacillus anthracis Sterne 34F2 spore germination after 1 hr2010Antimicrobial agents and chemotherapy, Dec, Volume: 54, Issue:12
Testing nucleoside analogues as inhibitors of Bacillus anthracis spore germination in vitro and in macrophage cell culture.
AID584550Cytotoxicity against mouse J774A1 cells2010Antimicrobial agents and chemotherapy, Dec, Volume: 54, Issue:12
Testing nucleoside analogues as inhibitors of Bacillus anthracis spore germination in vitro and in macrophage cell culture.
AID584547Antibacterial activity against Bacillus anthracis Sterne 34F2 infected in mouse J774A.1 cells assessed as protection against bacteria-induced cytotoxicity using propidium iodide staining after 3 hrs measured every hours for up to 7 hrs2010Antimicrobial agents and chemotherapy, Dec, Volume: 54, Issue:12
Testing nucleoside analogues as inhibitors of Bacillus anthracis spore germination in vitro and in macrophage cell culture.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (36)

TimeframeStudies, This Drug (%)All Drugs %
pre-19903 (8.33)18.7374
1990's3 (8.33)18.2507
2000's11 (30.56)29.6817
2010's17 (47.22)24.3611
2020's2 (5.56)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.36

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.36 (24.57)
Research Supply Index3.64 (2.92)
Research Growth Index5.00 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.36)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other37 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]